Ocean Biomedical, Inc. Common Stock
OCEA
OCEA was delisted on the 23rd of April, 2025.
34 hedge funds and large institutions have $93.4M invested in Ocean Biomedical, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.
800% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 1
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
31% more funds holding
Funds holding: 26 → 34 (+8)
14% more capital invested
Capital invested by funds: $81.8M → $93.4M (+$11.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$7.99M |
| 2 |
CCM
Context Capital Management
Lajolla,
California
|
+$4.99M |
| 3 |
SCC
Spring Creek Capital
Wichita,
Kansas
|
+$1.36M |
| 4 |
Millennium Management
New York
|
+$1M |
| 5 |
AI
Arena Investors
Purchase,
New York
|
+$554K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$588K |
| 2 |
SV
Starboard Value
New York
|
-$212K |
| 3 |
MSU
Mizuho Securities USA
New York
|
-$80.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
26
HRT Financial
New York
| $494K | – | – | – |
|
|
DWM
27
Dakota Wealth Management
Palm Beach Gardens,
Florida
| $434K | – | – | – |
|
|
AA
28
AQR Arbitrage
Greenwich,
Connecticut
| $416K | -$588K | -58,649 | -59% |
|
29
Walleye Trading
New York
| $363K | – | – | – |
|
30
Goldman Sachs
New York
| $363K | +$361K | +36,000 | New |
|
|
CC
31
Centiva Capital
New York
| $345K | +$343K | +34,195 | New |
|
|
EFI
32
EHP Funds Inc
Toronto,
Canada
| $252K | +$251K | +25,000 | New |
|
33
Blackstone Inc
New York
| $146K | +$145K | +14,500 | New |
|
|
ASM
34
ATW SPAC Management
New York
| $6.05K | – | – | – |
|
OCEA Hedge Fund Activity: Q1 2022 in Review
34 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q1 2022, worth a combined $93.4M — up 14% from $81.8M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new OCEA positions and 1 closed out — a net gain of 8 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $7.99M. The largest seller was AQR Arbitrage, cutting an estimated $588K.
- 34 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q1 2022, up from 26 in Q4 2021.
- Funds reported $93.4M of Ocean Biomedical, Inc. Common Stock stock for Q1 2022, up 14% quarter-over-quarter.
- 9 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q1 2022 and 1 closed out, a net change of +8 holders.
- The largest Ocean Biomedical, Inc. Common Stock buyer in Q1 2022 was Shaolin Capital Management, an estimated $7.99M added.
- The largest Ocean Biomedical, Inc. Common Stock seller in Q1 2022 was AQR Arbitrage, an estimated $588K sold.
Based on aggregated 13F filings for Q1 2022.